NeoGenomics, Inc. Just Beat EPS By 122%: Here's What Analysts Think Will Happen Next [Yahoo! Finance News]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance News
It's been a sad week for NeoGenomics, Inc. NASDAQ:NEO View our latest analysis for NeoGenomics Taking into account the latest results, the latest consensus from NeoGenomics's six analysts is for revenues of US$468.7m in 2020, which would reflect a solid 15% improvement in sales compared to the last 12 months. Statutory earnings per share are expected to surge 43% to US$0.11. Before this earnings report, analysts had been forecasting revenues of US$457.4m and earnings per share EPS) of US$0.19 in 2020. So it's pretty clear analysts have mixed opinions on NeoGenomics after the latest results; even though they upped their revenue numbers, it came at the cost of a large cut to per-share earnings expectations. Analysts also upgraded NeoGenomics's price target 6.8% to US$31.33, implying that the higher sales are expected to generate enough value to offset the forecast decline in earnings. Fixating on a single price target can be unwise though, since the consensus target is effectively the a
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- Felicia Williams Joins NeoGenomics Board of Directors [Yahoo! Finance]Yahoo! Finance
- Felicia Williams Joins NeoGenomics Board of DirectorsBusiness Wire
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
- NeoGenomics, Inc. (NASDAQ: NEO) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.MarketBeat
- NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
NEO
Earnings
- 11/5/24 - Beat
NEO
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/5/24 - Form 4
- NEO's page on the SEC website